Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 2, 2024 |
| Accession Number: | 0001493152-24-017312 | |||||
| Submission Type: | POS AM | |||||
|
Attachments
Disclaimer
Qualigen Therapeutics Inc. published this content on 02 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 May 2024 10:13:49 UTC.